Physician profile
Jay B Futterman
NPI 1952515645
$1,565.88
in general payments reported to CMS, 2019-2025
14 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $47.36 · 2021: $215 · 2022: $107 · 2023: $153 · 2024: $539 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $456.73 | 2019-2025 | Clareon, Centurion, Tryptyr |
| New World Medical,INC. | $191.79 | 2021-2024 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Novartis Pharmaceuticals Corporation | $177.63 | 2021-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $157.78 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $136.70 | 2024-2025 | Tecnis Simplicity, Tecnis Iol |
| Harrow Eye, LLC | $129.64 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $69.86 | 2024 | Envista Mx60 Iol |
| Aerie Pharmaceuticals, INC. | $67.86 | 2019-2021 | |
| Abbvie INC. | $52.10 | 2023-2024 | |
| Allergan, INC. | $43.24 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $27.26 | 2025 | |
| Horizon Therapeutics Plc | $23.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.17 | 2023 | Eylea |
| Medline Industries LP | $13.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Futterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.